Advanced Medical Solutions Grp PLC Notice of Annual General Meeting and Annual Report (1343M)
April 26 2018 - 1:00AM
UK Regulatory
TIDMAMS
RNS Number : 1343M
Advanced Medical Solutions Grp PLC
26 April 2018
26 April 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Annual Report and Accounts for the year ended
31 December 2017 and Notice of AGM
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, is pleased
to announce that in accordance with AIM Rules 20 and 26, the Annual
Report and Financial Statements for the year ended 31 December 2017
were posted to shareholders today and are available on the Investor
Relations section of the Company's website
http://www.admedsol.com/Investor-Relations.
The notice of meeting convening the Annual General Meeting of
the Company, which will be held on 6 June 2018 at 11 a.m. at 85
Gresham Street, London, EC2V 7NQ, was also posted to shareholders
today and is available on the Company's website.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com
/ Philippa Gardner
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb /
Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 600 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCIAMATMBJTBLP
(END) Dow Jones Newswires
April 26, 2018 02:00 ET (06:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024